Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Autolus Therapeutics (AUTL) has a market cap of $0.36 billion USD. According to our data, Autolus Therapeutics is ranked No.6320 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.36 B |
-43.19%
|
| Dec 31, 2024 | $0.63 B |
-63.51%
|
| Dec 29, 2023 | $1.71 B |
238.95%
|
| Dec 30, 2022 | $0.51 B |
-63.39%
|
| Dec 31, 2021 | $1.38 B |
-41.95%
|
| Dec 31, 2020 | $2.38 B |
-32.27%
|
| Dec 31, 2019 | $3.51 B |
-59.81%
|
| Dec 31, 2018 | $8.74 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Gilead Sciences
GILD
|
$131.93 B |
0.001 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.21 B |
0.002 M
|
USA
|
 bluebird bio
BLUE
|
$40.63 M |
0.000 M
|
USA
|
 Adaptimmune Therapeutics
ADAP
|
$59.52 M |
0.000 M
|
UK
|
 CRISPR Therapeutics
CRSP
|
$3.20 B |
-0.000 M
|
Switzerland
|
 Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
 Intellia Therapeutics
NTLA
|
$0.72 B |
-0.000 M
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.16 B |
0.000 M
|
USA
|
 Allogene Therapeutics
ALLO
|
$0.31 B |
-0.000 M
|
USA
|
 Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
USA
|
 Iovance Biotherapeutics
IOVA
|
$1.00 B |
0.000 M
|
USA
|
 Atara Biotherapeutics
ATRA
|
$34.80 M |
-0.000 M
|
USA
|
| Market Cap | = | AUTL Stock Price | * | AUTL Shares Outstanding |
| = | $1.34 | * | 0.27 B | |
| = | $0.36 B |